Skip to main content
. 2022 Jan 15;33:105177. doi: 10.1016/j.rinp.2022.105177

Table 2.

Incremental cost-effectiveness ratio for scenario A.

Strategy Infection averted Cost IAR ACER ICER
Strategy 3: u3(t) 1.4423×106 1.4063×103 1.2325 9.7498×104 9.7498×104
Strategy 2: u2(t) 1.6603×106 1.4077×103 1.5835 8.4784×104 6.4220×106
Strategy 4: u4(t) 1.8000×106 2.8098×103 1.2914 0.0016 0.0100
Strategy 1: u1(t), 2.0679×106 281.1135 1.5793 1.3594×104 −0.0004